{"id":816250,"date":"2025-02-21T09:07:53","date_gmt":"2025-02-21T14:07:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/"},"modified":"2025-02-21T09:07:53","modified_gmt":"2025-02-21T14:07:53","slug":"geron-to-participate-at-upcoming-investor-conferences-in-march-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/","title":{"rendered":"Geron to Participate at Upcoming Investor Conferences in March 2025"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Geron to Participate at Upcoming Investor Conferences in March 2025<\/b><\/p>\n<p>FOSTER CITY, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGeron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in fireside chats at the following investor conferences:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nTD Cowen 45th Annual Health Care Conference<br \/>\n<br \/>Monday, March 3<sup>rd<\/sup> at 3:10pm ET (Boston, MA)<\/p>\n<\/li>\n<li>\nLeerink Global Healthcare Conference<br \/>\n<br \/>Monday, March 10<sup>th<\/sup> 3:00pm ET (Miami, FL)<\/p>\n<\/li>\n<li>\nBarclays 27<sup>th<\/sup> Annual Global Healthcare Conference<br \/>\n<br \/>Tuesday, March 11<sup>th<\/sup> 10:30am ET (Miami, FL)<\/p>\n<\/li>\n<\/ul>\n<p>\nA live webcast of each fireside chat will be available through the Investors &amp; Media section of the Geron\u2019s website under <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.geron.com%2Finvestors%2Fevents%2Fdefault.aspx&amp;esheet=54211243&amp;newsitemid=20250221535654&amp;lan=en-US&amp;anchor=Events&amp;index=1&amp;md5=f8bce79a5eafe9356371fa00e3041e16\">Events<\/a>. A replay of the webcast will be archived and available on Geron\u2019s website for 30 days.\n<\/p>\n<p><b>About Geron<\/b><\/p>\n<p>\nGeron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO\u00ae (imetelstat) is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed\/refractory myelofibrosis (R\/R MF), as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.geron.com&amp;esheet=54211243&amp;newsitemid=20250221535654&amp;lan=en-US&amp;anchor=www.geron.com&amp;index=2&amp;md5=4a70e5bb04068aa7867a1b26c7558938\">www.geron.com<\/a> or follow us on LinkedIn.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250221535654\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250221535654\/en\/<\/a><\/span><\/p>\n<p>\nAron Feingold<br \/>\n<br \/>Vice President, Investor Relations and Corporate Communications\n<\/p>\n<p>\nKristen Kelleher<br \/>\n<br \/>Associate Director, Investor Relations and Corporate Communications\n<\/p>\n<p><a rel=\"nofollow\" href=\"mailto:investor@geron.com\">investor@geron.com<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"mailto:media@geron.com\">media@geron.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Massachusetts California Florida<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Pharmaceutical Clinical Trials Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250221535654\/en\/1950982\/3\/geron_r_rgb.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Geron to Participate at Upcoming Investor Conferences in March 2025 FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in fireside chats at the following investor conferences: TD Cowen 45th Annual Health Care Conference Monday, March 3rd at 3:10pm ET (Boston, MA) Leerink Global Healthcare Conference Monday, March 10th 3:00pm ET (Miami, FL) Barclays 27th Annual Global Healthcare Conference Tuesday, March 11th 10:30am ET (Miami, FL) A live webcast of each fireside chat will be available through the Investors &amp; Media section of the Geron\u2019s website under Events. A replay of the webcast will be archived and available on Geron\u2019s website for 30 days. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Geron to Participate at Upcoming Investor Conferences in March 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816250","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Geron to Participate at Upcoming Investor Conferences in March 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geron to Participate at Upcoming Investor Conferences in March 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Geron to Participate at Upcoming Investor Conferences in March 2025 FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in fireside chats at the following investor conferences: TD Cowen 45th Annual Health Care Conference Monday, March 3rd at 3:10pm ET (Boston, MA) Leerink Global Healthcare Conference Monday, March 10th 3:00pm ET (Miami, FL) Barclays 27th Annual Global Healthcare Conference Tuesday, March 11th 10:30am ET (Miami, FL) A live webcast of each fireside chat will be available through the Investors &amp; Media section of the Geron\u2019s website under Events. A replay of the webcast will be archived and available on Geron\u2019s website for 30 days. About &hellip; Continue reading &quot;Geron to Participate at Upcoming Investor Conferences in March 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-21T14:07:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Geron to Participate at Upcoming Investor Conferences in March 2025\",\"datePublished\":\"2025-02-21T14:07:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/\"},\"wordCount\":299,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/\",\"name\":\"Geron to Participate at Upcoming Investor Conferences in March 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-02-21T14:07:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geron to Participate at Upcoming Investor Conferences in March 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geron to Participate at Upcoming Investor Conferences in March 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/","og_locale":"en_US","og_type":"article","og_title":"Geron to Participate at Upcoming Investor Conferences in March 2025 - Market Newsdesk","og_description":"Geron to Participate at Upcoming Investor Conferences in March 2025 FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in fireside chats at the following investor conferences: TD Cowen 45th Annual Health Care Conference Monday, March 3rd at 3:10pm ET (Boston, MA) Leerink Global Healthcare Conference Monday, March 10th 3:00pm ET (Miami, FL) Barclays 27th Annual Global Healthcare Conference Tuesday, March 11th 10:30am ET (Miami, FL) A live webcast of each fireside chat will be available through the Investors &amp; Media section of the Geron\u2019s website under Events. A replay of the webcast will be archived and available on Geron\u2019s website for 30 days. About &hellip; Continue reading \"Geron to Participate at Upcoming Investor Conferences in March 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-21T14:07:53+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Geron to Participate at Upcoming Investor Conferences in March 2025","datePublished":"2025-02-21T14:07:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/"},"wordCount":299,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/","name":"Geron to Participate at Upcoming Investor Conferences in March 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-02-21T14:07:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221535654r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-to-participate-at-upcoming-investor-conferences-in-march-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Geron to Participate at Upcoming Investor Conferences in March 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816250"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816250\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}